Needham Reiterates Buy on Boston Scientific, Maintains $97 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.4%

Neg 0% Neu 86.4% Pos 0%

Needham analyst Mike Matson reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $97 price target.

Comments

No comments yet. Be the first!